Hiroshi Mitsumoto

Ten leaders in the field of ALS research put their heads together on Oct. 24, 2009

posted on October 30, 2009 - 5:18pm
  An all-day "think tank" to consider priorities for amyotrophic lateral sclerosis (ALS) research based on the latest information was conducted with ten of the leading scientists and clinicians in the field and senior MDA staff in Tucson, Ariz., on Saturday, Oct. 24, 2009. Each specialist introduced his or her area of expertise and led an approximately 20-minute discussion, gathering input...

Possible ALS biomarkers discussed at American Academy of Neurology meeting

posted on May 18, 2009 - 9:47am
The 61st annual meeting of the American Academy of Neurology (AAN), held in Seattle April 25-May 2, included several ALS-related presentations.

Modafinil (aka Provigil) may reduce common fatigue and daytime sleepiness in ALS

posted on March 15, 2009 - 9:00pm
Study results reported in the March 2009 issue of Muscle & Nerve indicate that modafinil (marketed under the brand name Provigil) "may be a promising intervention for fatigue in ALS (amyotrophic lateral sclerosis) patients." Fatigue and daytime sleepiness often accompany this disease. Hiroshi Mitsumoto, director of the Eleanor and Lou Gehrig MDA/ALS Research Center at Columbia University...